Janney Montgomery Scott’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Janney Montgomery Scott’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-231	Closed	-$18K	–	2772
2023 Q3	$18K	Hold	231	–	–	﹤0.01%	2539
2023 Q2	$17K	Hold	231	–	–	﹤0.01%	2618
2023 Q1	$23K	Hold	231	–	–	﹤0.01%	2430
2022 Q4	$12K	Hold	231	–	–	﹤0.01%	2542
2022 Q3	$12K	Buy	+231	New	+$13.6K	﹤0.01%	2477

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Janney Montgomery Scott's QNTM Position: Q4 2023 in Review

Janney Montgomery Scott sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2023, closing a stake of 231 shares — an estimated $18K sold.

Janney Montgomery Scott first reported a position in QNTM in Q3 2022 and held it in 5 quarters. The position peaked at $23K in Q1 2023. 14 funds tracked by Wall St. Rank hold QNTM as of Q4 2023.

Janney Montgomery Scott reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q4 2023 after selling out during the quarter.
Janney Montgomery Scott sold 231 Quantum Biopharma Class B Subordinate Voting Shares shares in Q4 2023, an estimated $18K.
Janney Montgomery Scott first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2022 and held it in 5 quarters.
Janney Montgomery Scott's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $23K in Q1 2023.
14 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2023.

Based on Janney Montgomery Scott's 13F filing for Q4 2023, filed 8 Feb 2024.